Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes fromFinra
Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Top Ranked Growth Stocks to Buy for November 25th
LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care decisions, today announced that members of the executive management team will participate in a virtual fireside chat at the 3rd Annual Evercore ISI HealthCONx Conference on Thursday, Dec. 3 at 1:50 p.m. ET.
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high growth prospects. Some such stocks are LH, ODP, HMC, SPB and BCC.
The Zacks Analyst Blog Highlights: ODP, WESCO, General Motors, Laboratory Corp and Knight-Swift
Circuit Clinical®, a network of physicians and clinical research professionals devoted to and passionate about bringing clinical research to everyone; Riverside Medical Group (RMG), a leading regional medical practice in New Jersey; and LabCorp, (NYSE: LH), a leading global life sciences company, today announced a multi-faceted collaboration that will enable RMG's patients to participate in clinical trials of new treatments and therapies within their own doctor's office.
Top Ranked Growth Stocks to Buy for November 20th
At this stage, it makes good sense to buy those stocks on the dip that could prove to be valuable once the rally resumes. These are Office Depot (ODP), WESCO (WCC), General Motors (GM), Laboratory Corp. of America (LH) and Knight-Swift Transportation (KNX).
Laboratory Corporation Of America saw its IBD SmartSelect Composite Rating jump to 97 Thursday, up from 94 the day before.
LabCorp (LH) could produce exceptional returns because of its solid growth attributes.
Is (LH) Outperforming Other Medical Stocks This Year?